For GCIH management, the Joint British Diabetes Societies (JBDS) and the American Diabetes Association recommend the sulfonylurea (SU) agent gliclazide and Neutral Protamine Hagedorn (NPH) insulin [9,10]. Here, INS is linked to diabetes mellitus.